<DOC>
	<DOCNO>NCT00006078</DOCNO>
	<brief_summary>RATIONALE : Chemoprevention therapy use certain drug try prevent development cancer . The use lycopene may effective way prevent prostate cancer . PURPOSE : Phase I trial study effectiveness lycopene prevent prostate cancer .</brief_summary>
	<brief_title>Lycopene In Preventing Prostate Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Determine dose limit toxicity maximum tolerate dose lycopene administer orally food base delivery system healthy male subject 18-45 year age chemoprevention prostate cancer . - Determine pharmacokinetics regimen population . - Determine dose range regimen use 3 month multiple dose study , base toxicity , pharmacokinetics feasibility result present study population . OUTLINE : This dose-escalation study . Patients receive single dose oral lycopene mixture tomato paste , water , olive oil 15 minute day 1 . Patients ask maintain diet contains negligible carotinoid 28 day . Cohorts 5 patient receive escalate dos lycopene maximum tolerate dose ( MTD ) determine . The MTD define dose precede 2 5 patient experience dose limit toxicity . Patients follow weekly 4 week . PROJECTED ACCRUAL : A total 5-25 patient accrue study .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Lycopene</mesh_term>
	<mesh_term>Carotenoids</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Normal healthy male judge good medical condition base history physical exam confirm absence chronic medical condition Baseline serum lycopene le 600 nM PATIENT CHARACTERISTICS : Age : 18 45 Performance status : Karnofsky 100 % Life expectancy : Not specify Hematopoietic : Hematologic function normal Hepatic : Liver function normal No hepatic disease Renal : Kidney function normal No renal disease Cardiovascular : No hypertension require medication No cardiovascular disease Normal EKG Other : No evidence psychiatric disorder Must within 15 % ideal body weight base standard weight table No history smoking within past 3 month At least 72 hour since prior alcohol consumption history alcohol abuse No history gastrointestinal malabsorption condition could affect drug absorption No allergy tomato base product No active malignancy site No illness would pose threat additional risk ( e.g. , thyroid disease , diabetes mellitus ) PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : Not specify Endocrine therapy : Not specify Radiotherapy : Not specify Surgery : Not specify Other : At least 14 day since prior prescription drug No concurrent regular prescription medication At least 30 day since prior experimental drug No concurrent participation experimental trial</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2004</verification_date>
	<keyword>prostate cancer</keyword>
</DOC>